UiPath (PATH) 10-Q 3 Jun 24 2025 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Apr. 30, 2024	May 30, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2024
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		490,324,835
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 1,146,618	$ 1,061,678
Restricted cash	438	438
Marketable securities	788,920	818,145
Accounts receivable, net of allowance for credit losses of $1,827 and $1,119, respectively	270,621	436,296
Contract assets	88,146	84,197
Deferred contract acquisition costs	76,309	74,678
Prepaid expenses and other current assets	98,146	104,980
Total current assets	2,469,198	2,580,412
Marketable securities, non-current	962	0
Contract assets, non-current	9,960	6,214
Deferred contract acquisition costs, non-current	145,175	154,317
Property and equipment, net	22,741	23,982
Operating lease right-of-use assets	60,458	56,072
Intangible assets, net	12,577	14,704
Goodwill	88,384	89,026
Deferred tax assets	3,900	4,678
Other assets, non-current	31,621	25,353
Total assets	2,844,976	2,954,758
Current liabilities
Accounts payable	6,864	3,447
Accrued expenses and other current liabilities	84,793	83,997
Accrued compensation and employee benefits	40,663	137,442
Deferred revenue	465,216	486,805
Total current liabilities	597,536	711,691
Deferred revenue, non-current	150,934	161,027
Operating lease liabilities, non-current	62,772	58,713
Other liabilities, non-current	6,730	7,213
Total liabilities	817,972	938,644
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	0	0
Treasury stock, at cost, $6,778 and $5,840 shares, respectively	(124,620)	(102,615)
Additional paid-in capital	4,089,795	4,024,079
Accumulated other comprehensive income	4,740	8,825
Accumulated deficit	(1,942,917)	(1,914,181)
Total stockholders’ equity	2,027,004	2,016,114
Total liabilities and stockholders’ equity	2,844,976	2,954,758
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Accounts receivable, allowance for doubtful accounts	$ 1,827	$ 1,119
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock, at cost (in shares)	6,778	5,840
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	496,893	492,660
Common stock, shares outstanding (in shares)	490,115	486,820
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenue:
Total revenue	$ 335,112	$ 289,588
Cost of revenue:
Total cost of revenue	55,325	43,667
Gross profit	279,787	245,921
Operating expenses:
Sales and marketing	180,139	160,406
Research and development	85,603	75,342
General and administrative	63,510	56,584
Total operating expenses	329,252	292,332
Operating loss	(49,465)	(46,411)
Interest income	13,830	13,848
Other income, net	10,679	4,294
Loss before income taxes	(24,956)	(28,269)
Provision for income taxes	3,780	3,632
Net loss	$ (28,736)	$ (31,901)
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)
Weighted-average shares used in computing net loss per share, basic (in shares)	569,925	557,878
Weighted-average shares used in computing net loss per share, diluted (in shares)	569,925	557,878
Licenses
Revenue:
Total revenue	$ 140,128	$ 134,039
Cost of revenue:
Total cost of revenue	2,601	2,547
Subscription services
Revenue:
Total revenue	185,131	146,352
Cost of revenue:
Total cost of revenue	36,754	23,078
Professional services and other
Revenue:
Total revenue	9,853	9,197
Cost of revenue:
Total cost of revenue	$ 15,970	$ 18,042

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (28,736)	$ (31,901)
Other comprehensive (loss) income, net of tax:
Unrealized (loss) gain on available-for-sale marketable securities, net	(511)	143
Foreign currency translation adjustments	(3,574)	2,319
Other comprehensive (loss) income, net	(4,085)	2,462
Comprehensive loss	$ (32,821)	$ (29,439)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023				474,160	82,453	0
Beginning balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1	$ 0	$ 3,736,838	$ 7,612	$ (1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				898
Issuance of common stock upon exercise of stock options	1,175						1,175
Issuance of common stock upon settlement of restricted stock units (in shares)				4,246
Tax withholdings on settlement of restricted stock units (in shares)				(1,463)
Tax withholdings on settlement of restricted stock units	(25,697)						(25,697)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215						4,215
Stock-based compensation	85,125						85,125
Other comprehensive (loss) income, net	2,462							2,462
Net loss	(31,901)	$ (27,186)	$ (4,715)						(31,901)
Ending balance (in shares) at Apr. 30, 2023				478,122	82,453	0
Ending balance at Apr. 30, 2023	1,955,537			$ 5	$ 1	$ 0	3,801,656	10,074	(1,856,199)
Beginning balance (in shares) at Jan. 31, 2024		492,660	82,453	492,660	82,453	(5,840)
Beginning balance at Jan. 31, 2024	$ 2,016,114			$ 5	$ 1	$ (102,615)	4,024,079	8,825	(1,914,181)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,428			1,426
Issuance of common stock upon exercise of stock options	$ 311						311
Issuance of common stock upon settlement of restricted stock units (in shares)				3,843
Tax withholdings on settlement of restricted stock units (in shares)				(1,317)
Tax withholdings on settlement of restricted stock units	(29,944)						(29,944)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	6,564						6,564
Repurchase of Class A common stock (in shares)				(900)		(938)
Repurchase of Class A Common Stock	(22,005)					$ (22,005)
Stock-based compensation	88,785						88,785
Other comprehensive (loss) income, net	(4,085)							(4,085)
Net loss	(28,736)	$ (24,579)	$ (4,157)						(28,736)
Ending balance (in shares) at Apr. 30, 2024		496,893	82,453	496,893	82,453	(6,778)
Ending balance at Apr. 30, 2024	$ 2,027,004			$ 5	$ 1	$ (124,620)	$ 4,089,795	$ 4,740	$ (1,942,917)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities
Net loss	$ (28,736)	$ (31,901)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,902	5,616
Amortization of deferred contract acquisition costs	18,467	14,072
Net amortization on marketable securities	(9,268)	(4,097)
Stock-based compensation expense	88,727	85,048
Charitable donation of Class A common stock	6,564	4,215
Non-cash operating lease expense	3,476	3,071
Provision for deferred income taxes	569	(267)
Other non-cash (credits) charges, net	(966)	624
Changes in operating assets and liabilities:
Accounts receivable	162,444	141,557
Contract assets	(7,645)	660
Deferred contract acquisition costs	(12,437)	(15,499)
Prepaid expenses and other assets	(803)	(5,860)
Accounts payable	3,936	(2,130)
Accrued expenses and other liabilities	(4,195)	(10,547)
Accrued compensation and employee benefits	(96,403)	(93,390)
Operating lease liabilities, net	(3,912)	(2,946)
Deferred revenue	(24,683)	(20,885)
Net cash provided by operating activities	100,037	67,341
Cash flows from investing activities
Purchases of marketable securities	(323,137)	(215,391)
Maturities of marketable securities	360,141	78,955
Purchases of property and equipment	(1,238)	(1,870)
Other investing, net	0	2,754
Net cash provided by (used in) investing activities	35,766	(135,552)
Cash flows from financing activities
Repurchases of Class A common stock	(22,005)	0
Proceeds from exercise of stock options	312	1,187
Payments of tax withholdings on net settlement of equity awards	(28,959)	(25,902)
Net payments of tax withholdings on sell-to-cover equity award transactions	0	(645)
Proceeds from employee stock purchase plan contributions	4,916	4,730
Net cash used in financing activities	(45,736)	(20,630)
Effect of exchange rate changes	(5,127)	(1,702)
Net increase (decrease) in cash, cash equivalents, and restricted cash	84,940	(90,543)
Cash, cash equivalents, and restricted cash - beginning of period	1,062,116	1,402,119
Cash, cash equivalents, and restricted cash - end of period	1,147,056	1,311,576
Supplemental disclosure of cash flow information
Cash paid for interest	45	86
Cash paid for income taxes	7,391	6,218
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases included in accounts payable	50	65
Receivable from maturities of marketable securities included in prepaid expense and other current assets	0	20,315
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	$ 4,304	$ 1,996

Organization and Description of

Organization and Description of Business	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies , in the notes to consolidated financial statements included in the 2024 Form 10-K. There have been no significant changes to such policies during the three months ended April 30, 2024. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended April 30, 2024 and 2023, we recognized foreign currency transaction gains (losses) of $2.8 million and $(0.8) million, respectively. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2024 and January 31, 2024, 95% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three months ended April 30, 2024 and 2023, no single customer accounted for 10% or more of our total revenue. As of April 30, 2024 and January 31, 2024, no single customer accounted for 10% or more of our accounts receivable. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended April 30, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Americas (1) $ 153,111 46 % $ 123,452 43 % Europe, Middle East, and Africa 104,627 31 % 96,931 33 % Asia-Pacific (2) 77,374 23 % 69,205 24 % Total revenue $ 335,112 100 % $ 289,588 100 % (1) Revenue from the U.S. represented 42% and 38% of our total revenues for the three months ended April 30, 2024 and 2023, respectively. (2) Revenue from Japan represented 13% and 13% of our total revenues for the three months ended April 30, 2024 and 2023, respectively. Deferred Revenue During the three months ended April 30, 2024 and 2023, we recognized $182.3 million and $150.6 million of revenue that was included in the deferred revenue balance as of January 31, 2024 and 2023, respectively . Remaining Performance Obligations Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of April 30, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,100.6 million, which consists of $616.2 million of billed consideration and $484.4 million of unbilled consideration. We expect to recognize 62% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter. Deferred Contract Acquisition Costs Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $18.5 million and $14.1 million for the three months ended April 30, 2024 and 2023, respectively, and is recorded in sal es and marketing expense in the condensed consolidated statements of operations.

Marketable Securities

Marketable Securities	3 Months Ended
	Apr. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The following is a summary of our marketable securities (in thousands): As of April 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Commercial paper $ 978 $ — $ — $ 978 Treasury bills and U.S. government securities (1) 710,071 — (506) 709,565 Corporate bonds (2) 24,778 — (60) 24,718 Agency bonds 54,661 — (40) 54,621 Total marketable securities $ 790,488 $ — $ (606) $ 789,882 (1) Additional treasury bills with both amortized cost and estimated fair value of $19.8 million are included in cash and cash equivalents due to their original maturity of three months or less. (2) Additional corporate bonds with both amortized cost and estimated fair value of $6.1 million are included in cash and cash equivalents due to their original maturity of three months or less. As of January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Treasury bills and U.S. government securities 641,263 29 (100) 641,192 Corporate bonds 1,993 — (2) 1,991 Agency bonds 174,990 — (28) 174,962 Total marketable securities $ 818,246 $ 29 $ (130) $ 818,145 As of April 30, 2024 and January 31, 2024, $1.0 million and none, respectively, of our marketable securities had remaining contractual maturities of one year or more. As of April 30, 2024 and January 31, 2024, $3.1 million and $3.3 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2024 and January 31, 2024. Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

Fair Value Measurement

Fair Value Measurement	3 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2024 and January 31, 2024 (in thousands): As of April 30, 2024 Level 1 Level 2 Total Money market $ 499,276 $ — $ 499,276 Treasury bills 19,765 — 19,765 Corporate bonds — 6,065 6,065 Total cash equivalents 519,041 6,065 525,106 Commercial paper — 978 978 Treasury bills and U.S. government securities 709,565 — 709,565 Corporate bonds — 24,718 24,718 Agency bonds 54,621 — 54,621 Total marketable securities 764,186 25,696 789,882 Total $ 1,283,227 $ 31,761 $ 1,314,988 As of January 31, 2024 Level 1 Level 2 Total Money market $ 509,053 $ — $ 509,053 Total cash equivalents 509,053 — 509,053 Treasury bills and U.S. government securities 641,192 — 641,192 Corporate bonds — 1,991 1,991 Agency bonds 174,962 — 174,962 Total marketable securities 816,154 1,991 818,145 Total $ 1,325,207 $ 1,991 $ 1,327,198 Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper and corporate bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of April 30, 2024 or January 31, 2024.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
	Apr. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets, Net Acquired intangible assets, net consisted of the following as of April 30, 2024 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (years) Developed technology $ 28,572 $ (18,166) $ 10,406 2.6 Customer relationships 8,228 (6,829) 1,399 1.2 Trade names and trademarks 271 (271) — 0.0 Other intangibles 1,231 (459) 772 6.9 Total $ 38,302 $ (25,725) $ 12,577 Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (years) Developed technology $ 28,807 $ (16,881) $ 11,926 2.8 Customer relationships 8,266 (6,306) 1,960 1.3 Trade names and trademarks 272 (266) 6 0.2 Other intangibles 1,231 (419) 812 7.0 Total $ 38,576 $ (23,872) $ 14,704 We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended April 30, 2024 and 2023 was $2.0 million and $2.1 million, respectively. Expected future amortization expense related to intangible assets was as follows as of April 30, 2024 (in thousands): Amount Remainder of year ending January 31, 2025 $ 4,615 Year ending January 31, 2026 4,079 2027 2,428 2028 1,153 2029 101 Thereafter 201 Total $ 12,577 Goodwill Changes in the carrying amount of goodwill during the three months ended April 30, 2024 were as follows (in thousands): Carrying Amount Balance as of January 31, 2024 $ 89,026 Effect of foreign currency translation (642) Balance as of April 30, 2024 $ 88,384

Operating Leases

Operating Leases	3 Months Ended
	Apr. 30, 2024
Leases [Abstract]
Operating Leases	Operating Leases Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. F or purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees. Lease costs are presented below (in thousands): Three Months Ended April 30, 2024 2023 Operating lease cost $ 3,476 $ 3,071 Short-term lease cost 1,123 1,300 Variable lease cost 523 621 Sublease income (1) — (532) Total $ 5,122 $ 4,460 (1) Included in other income, net in the condensed consolidated statements of operations. The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of April 30, January 31, Weighted-average remaining lease term (years) 10.5 10.7 Weighted-average discount rate 7.2 % 7.1 % Future undiscounted lease payments for our operating lease liabilities as of April 30, 2024 were as follows (in thousands): Amount Remainder of year ending January 31, 2025 $ 9,097 Year ending January 31, 2026 12,110 2027 11,875 2028 10,444 2029 7,137 Thereafter 49,852 Total operating lease payments 100,515 Less: imputed interest (29,519) Total operating lease liabilities $ 70,996 As of April 30, 2024, we had non-cancellable commitments in the amount of $26.3 million related to operating leases of real estate facilities that have not yet commenced. Current operating lease liabilities of $8.2 million and $8.4 million were included in accrued expenses and other current liabilities Supplemental cash flow information related to leases for the three months ended April 30, 2024 and 2023 was as follows (in thousands): Three Months Ended April 30, 2024 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 3,653 $ 2,615 Operating lease ROU assets obtained in exchange for new operating lease liabilities 7,044 1,993

Condensed Consolidated Balanc_3

Condensed Consolidated Balance Sheet Components	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Balance Sheet Components	Condensed Consolidated Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of April 30, January 31, Prepaid expenses and service credits $ 76,695 $ 87,781 Other current assets 21,451 17,199 Prepaid expenses and other current assets $ 98,146 $ 104,980 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of April 30, January 31, Computers and equipment $ 23,706 $ 23,767 Leasehold improvements 24,307 21,756 Furniture and fixtures 6,708 6,640 Construction in progress 2,720 4,560 Other 631 632 Property and equipment, gross 58,072 57,355 Less: accumulated depreciation (35,331) (33,373) Property and equipment, net $ 22,741 $ 23,982 Depreciation expense for the three months ended April 30, 2024 and 2023 was $2.3 million and $3.0 million, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of April 30, January 31, Accrued expenses $ 22,256 $ 18,458 Withholding tax from employee equity transactions 4,216 3,277 Employee stock purchase plan withholdings 8,483 3,618 Payroll taxes and other benefits payable 5,424 3,888 Income taxes payable 6,833 7,140 Value-added taxes payable 3,837 6,480 Operating lease liabilities, current 8,224 8,357 Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024) 5,570 5,570 Rebates payable to partners 6,364 7,289 Other 13,586 19,920 Accrued expenses and other current liabilities $ 84,793 $ 83,997

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit We had a total of $2.8 million and $2.6 million in letters of credit outstanding in favor of certain landlords for office space as of April 30, 2024 and January 31, 2024, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2026. Indemnification In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of April 30, 2024 and January 31, 2024, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote. Defined Contribution Plans We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans was $6.2 million and $5.6 million for the three months ended April 30, 2024 and 2023, respectively. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters which arise in the ordinary course of business. In accordance with ASC 4 50, Contingencies , we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. UiPath and certain of its officers are currently parties to the following litigation matters: On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, then Co-CEO Daniel Dines, and CFO Ashim Gupta, captioned In re UiPath, Inc. Securities Litigation (the "Securities Action"). The initial complaint asserted claims under Sections 10(b) and 20(a) of the Exchange Act, and alleged that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. On January 26, 2024, the lead plaintiff in the Securities Action filed an amended complaint, and on March 26, 2024, filed a further amended complaint, which alleges Securities Act claims under Sections 11 and 15 as well as Exchange Act claims under Section 10(b), Rule 10b-5, and Section 20(a). In support of the Securities Act claims, the plaintiff alleges material misstatements and omissions in UiPath’s April 2021 Registration Statement, including regarding UiPath’s competitive position and its financial results. The operative complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and September 27, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. Defendants moved to dismiss the second amended complaint on April 23, 2024. Plaintiffs filed their opposition to defendants' motion to dismiss on May 21, 2024. On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and then Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al . The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the Securities Action and by causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees and certain changes to UiPath’s corporate governance and internal controls. Similar cases were filed in the District of Delaware and in the Southern District of New York (together with Polilingua Limited v. Daniel Dines, et al, the "Derivative Litigations"). The Derivative Litigations are at an early stage; in each case the matter has been stayed, pending the outcome of the Court's decision on the defendants' motion to dismiss the Securities Action. We have not recorded any accrual related to the aforementioned litigation matters as of April 30, 2024, as we believe a loss in these matters is neither probable nor estimable at this time. Warranty We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made. Other Matters Our indirect tax positions are subject to audit in multiple jurisdictions globally, with a key focus on our largest operational territories, including the U.S., Romania, India, and the U.K. Our Romanian subsidiary was subjected to audits by the Agenția Națională de Administrare Fiscală ("ANAF") for value-added tax and corporate income tax for the periods January 2020 through January 2022 and January 2018 through January 2022, respectively, which were completed during the three months ended April 30, 2024. With regard to the value-added tax audit, an assessment has been issued; we disagree with this assessment and are in the process of appealing. We have not recorded any reserves related to this audit as of April 30, 2024 as it is not probable that a material loss has been incurred. For additional information regarding the corporate income tax audit, refer to Note 12, Income Taxes . Non-Cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and credits toward purchase of products and services from strategic alliance partners. As of April 30, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2025 $ 66,202 Year ending January 31, 2026 69,593 2027 23,856 2028 8,443 2029 17 Thereafter 1 Total $ 168,112

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Stock Repurchase Program On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future. During the three months ended April 30, 2024, we repurchased 0.9 million shares of our Class A common stock at an average price of $23.46 per share (inclusive of brokerage commission). Charitable Donations of Class A Common Stock We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. We contributed 0.3 million shares of our Class A common stock during the three months ended April 30, 2024 and 0.3 million shares of our Class A common stock during the three months ended April 30, 2023 to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $6.6 million and $4.2 million were recorded within general and administrative expense in the condensed consolidated statements of operations for the three months ended April 30, 2024 and 2023, respectively. Accumulated Other Comprehensive Income For the three months ended April 30, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income Balance as of January 31, 2024 $ 8,925 $ (100) $ 8,825 Other comprehensive loss, net of tax (3,574) (511) (4,085) Balance as of April 30, 2024 $ 5,351 $ (611) $ 4,740 Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive income, net of tax 2,319 143 2,462 Balance as of April 30, 2023 $ 10,550 $ (476) $ 10,074

Equity Incentive Plans and Stoc

Equity Incentive Plans and Stock-Based Compensation	3 Months Ended
	Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans and Stock-Based Compensation	Equity Incentive Plans and Stock-Based Compensation 2021 Stock Plan In April 2021, prior to and in connection with our initial public offering ("IPO"), we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, RSAs, RSUs, PSUs, and other forms of awards. As of April 30, 2024, we have reserved 202.2 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase. 2021 Employee Stock Purchase Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of April 30, 2024, the ESPP authorizes the issuance of 27.2 million shares of our Class A common stock under purchase rights granted to our employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of the offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date. Stock Options Stock option activity during the three months ended April 30, 2024 was as follows: Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value Outstanding as of January 31, 2024 11,080 $ 3.49 7.8 $ 216,010 Granted 1,670 $ 0.10 Exercised (1,428) $ 0.22 Forfeited (40) $ 0.10 Outstanding as of April 30, 2024 11,282 $ 3.41 8.0 $ 175,549 Vested and exercisable as of April 30, 2024 4,779 $ 5.09 6.8 $ 66,332 The weighted-average grant date fair value of stock options granted during the three months ended April 30, 2024 was $21.26 per share. The intrinsic value of stock options exercised during the three months ended April 30, 2024 was $31.4 million. Unrecognized compensation expense associated with unvested stock options granted and outstanding as of April 30, 2024 was approximately $122.5 million, which is to be recognized over a weighted-average remaining period of 2.2 years. Restricted Stock Units RSU activity during the three months ended April 30, 2024 was as follows: RSUs Weighted-Average Grant Date Fair Value Per Share Unvested as of January 31, 2024 31,272 $ 19.89 Granted 9,479 $ 21.45 Vested (3,843) $ 21.22 Forfeited (1,497) $ 20.76 Unvested as of April 30, 2024 35,411 $ 20.13 The fair value of RSUs released during the three months ended April 30, 2024 was $87.4 million. As of April 30, 2024, total unrecognized compensation expense related to unvested RSUs was approximately $661.6 million, which is to be recognized over a weighted-average remaining period of 2.4 years. Employee Stock Purchase Plan Awards As of April 30, 2024, total unrecognized compensation expense related to the ESPP was approximately $0.9 million, which is to be recognized over a weighted-average remaining period of 0.1 years. Stock-Based Compensation Associated with Business Acquisition At the closing of the acquisition of Re:infer LTD on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of April 30, 2024, total unrecognized compensation expense related to these shares was $3.2 million, which is to be recognized over a weighted-average remaining period of 1.3 years. Stock-Based Compensation Expense Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended April 30, 2024 2023 Cost of subscription services revenue $ 4,276 $ 3,178 Cost of professional services and other revenue 2,470 2,699 Sales and marketing 36,216 33,123 Research and development 29,142 24,773 General and administrative 16,623 21,275 Total $ 88,727 $ 85,048

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. We had a provision for income taxes of $3.8 million, reflecting an effective tax rate of (15.1)%, and $3.6 million, reflecting an effective tax rate of (12.8)%, for the three months ended April 30, 2024 and 2023, respectively. For the three months ended April 30, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the three months ended April 30, 2024, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. will not be realized. Accordingly, we have recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of April 30, 2024, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. Our tax positions are subject to income tax audits in multiple tax jurisdictions globally, with a currently open audit in India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. Our Romanian subsidiary was subjected to a corporate income tax audit by ANAF for the period from January 2018 through January 2022, which was completed during the three months ended April 30, 2024. Certain deductions have been disallowed, resulting in a proposed reduction of net operating loss carryforwards of approximately $66.7 million. We are in the process of appealing this disallowance. In addition, we have engaged in two bilateral transfer pricing negotiations for our transfer pricing model, one between the U.S. and Romania, and one between Japan and Romania. These negotiations are still underway and the authorities are in the process of determining the cost sharing allocations between the respective countries. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us. In 2023, Romania adopted an alternative minimum tax that is applicable to all corporate taxpayers, including those reporting a net loss, for tax years commencing after January 1, 2024. As this tax is based on gross receipts, associated expense is included in operating expenses in our condensed consolidated statements of operations, and is not accounted for as income taxes.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts): Three Months Ended April 30, 2024 2023 Class A Class B Class A Class B Numerator: Net loss $ (24,579) $ (4,157) $ (27,186) $ (4,715) Denominator: Weighted-average shares used in computing net loss per share, basic and diluted 487,472 82,453 475,425 82,453 Net loss per share, basic and diluted $ (0.05) $ (0.05) $ (0.06) $ (0.06) Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands): Three Months Ended April 30, 2024 2023 Class A Class B Class A Class B Unvested RSUs 32,230 — 37,351 — Outstanding stock options 10,946 — 13,883 — Shares subject to repurchase from RSAs and early exercised stock options 28 — 63 — Shares issuable under ESPP 690 — 897 — Returnable shares issued in connection with business acquisition 274 — 427 — Total 44,168 — 52,621 —

Subsequent Events

Subsequent Events	3 Months Ended
	Apr. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On May 3, 2024, we agreed to invest approximately $35.2 million, split between cash investment for equity and purchase of convertible bonds, in an initial seed round in H.AI (the “H company”), a France-based global foundation model and agentic artificial intelligence ("AI") company.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign Currency
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2024 and January 31, 2024, 95% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Geographical Region	The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended April 30, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Americas (1) $ 153,111 46 % $ 123,452 43 % Europe, Middle East, and Africa 104,627 31 % 96,931 33 % Asia-Pacific (2) 77,374 23 % 69,205 24 % Total revenue $ 335,112 100 % $ 289,588 100 % (1) Revenue from the U.S. represented 42% and 38% of our total revenues for the three months ended April 30, 2024 and 2023, respectively. (2) Revenue from Japan represented 13% and 13% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

Marketable Securities (Tables)

Marketable Securities (Tables)	3 Months Ended
	Apr. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	The following is a summary of our marketable securities (in thousands): As of April 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Commercial paper $ 978 $ — $ — $ 978 Treasury bills and U.S. government securities (1) 710,071 — (506) 709,565 Corporate bonds (2) 24,778 — (60) 24,718 Agency bonds 54,661 — (40) 54,621 Total marketable securities $ 790,488 $ — $ (606) $ 789,882 (1) Additional treasury bills with both amortized cost and estimated fair value of $19.8 million are included in cash and cash equivalents due to their original maturity of three months or less. (2) Additional corporate bonds with both amortized cost and estimated fair value of $6.1 million are included in cash and cash equivalents due to their original maturity of three months or less. As of January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Treasury bills and U.S. government securities 641,263 29 (100) 641,192 Corporate bonds 1,993 — (2) 1,991 Agency bonds 174,990 — (28) 174,962 Total marketable securities $ 818,246 $ 29 $ (130) $ 818,145

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2024 and January 31, 2024 (in thousands): As of April 30, 2024 Level 1 Level 2 Total Money market $ 499,276 $ — $ 499,276 Treasury bills 19,765 — 19,765 Corporate bonds — 6,065 6,065 Total cash equivalents 519,041 6,065 525,106 Commercial paper — 978 978 Treasury bills and U.S. government securities 709,565 — 709,565 Corporate bonds — 24,718 24,718 Agency bonds 54,621 — 54,621 Total marketable securities 764,186 25,696 789,882 Total $ 1,283,227 $ 31,761 $ 1,314,988 As of January 31, 2024 Level 1 Level 2 Total Money market $ 509,053 $ — $ 509,053 Total cash equivalents 509,053 — 509,053 Treasury bills and U.S. government securities 641,192 — 641,192 Corporate bonds — 1,991 1,991 Agency bonds 174,962 — 174,962 Total marketable securities 816,154 1,991 818,145 Total $ 1,325,207 $ 1,991 $ 1,327,198

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Apr. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Acquired intangible assets, net consisted of the following as of April 30, 2024 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (years) Developed technology $ 28,572 $ (18,166) $ 10,406 2.6 Customer relationships 8,228 (6,829) 1,399 1.2 Trade names and trademarks 271 (271) — 0.0 Other intangibles 1,231 (459) 772 6.9 Total $ 38,302 $ (25,725) $ 12,577 Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (years) Developed technology $ 28,807 $ (16,881) $ 11,926 2.8 Customer relationships 8,266 (6,306) 1,960 1.3 Trade names and trademarks 272 (266) 6 0.2 Other intangibles 1,231 (419) 812 7.0 Total $ 38,576 $ (23,872) $ 14,704
Schedule of Expected Future Amortization Expenses Related to Intangible Assets	Expected future amortization expense related to intangible assets was as follows as of April 30, 2024 (in thousands): Amount Remainder of year ending January 31, 2025 $ 4,615 Year ending January 31, 2026 4,079 2027 2,428 2028 1,153 2029 101 Thereafter 201 Total $ 12,577
Schedule of Changes in Carrying Amounts of Goodwill	Changes in the carrying amount of goodwill during the three months ended April 30, 2024 were as follows (in thousands): Carrying Amount Balance as of January 31, 2024 $ 89,026 Effect of foreign currency translation (642) Balance as of April 30, 2024 $ 88,384

Operating Leases (Tables)

Operating Leases (Tables)	3 Months Ended
	Apr. 30, 2024
Leases [Abstract]
Schedule of Lease Costs and Supplemental Cash Flow Information	Lease costs are presented below (in thousands): Three Months Ended April 30, 2024 2023 Operating lease cost $ 3,476 $ 3,071 Short-term lease cost 1,123 1,300 Variable lease cost 523 621 Sublease income (1) — (532) Total $ 5,122 $ 4,460 (1) Included in other income, net in the condensed consolidated statements of operations. Supplemental cash flow information related to leases for the three months ended April 30, 2024 and 2023 was as follows (in thousands): Three Months Ended April 30, 2024 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 3,653 $ 2,615 Operating lease ROU assets obtained in exchange for new operating lease liabilities 7,044 1,993
Schedule of Weighted-average Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of April 30, January 31, Weighted-average remaining lease term (years) 10.5 10.7 Weighted-average discount rate 7.2 % 7.1 %
Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities	Future undiscounted lease payments for our operating lease liabilities as of April 30, 2024 were as follows (in thousands): Amount Remainder of year ending January 31, 2025 $ 9,097 Year ending January 31, 2026 12,110 2027 11,875 2028 10,444 2029 7,137 Thereafter 49,852 Total operating lease payments 100,515 Less: imputed interest (29,519) Total operating lease liabilities $ 70,996

Condensed Consolidated Balanc_4

Condensed Consolidated Balance Sheet Components (Tables)	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of April 30, January 31, Prepaid expenses and service credits $ 76,695 $ 87,781 Other current assets 21,451 17,199 Prepaid expenses and other current assets $ 98,146 $ 104,980
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of April 30, January 31, Computers and equipment $ 23,706 $ 23,767 Leasehold improvements 24,307 21,756 Furniture and fixtures 6,708 6,640 Construction in progress 2,720 4,560 Other 631 632 Property and equipment, gross 58,072 57,355 Less: accumulated depreciation (35,331) (33,373) Property and equipment, net $ 22,741 $ 23,982
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of April 30, January 31, Accrued expenses $ 22,256 $ 18,458 Withholding tax from employee equity transactions 4,216 3,277 Employee stock purchase plan withholdings 8,483 3,618 Payroll taxes and other benefits payable 5,424 3,888 Income taxes payable 6,833 7,140 Value-added taxes payable 3,837 6,480 Operating lease liabilities, current 8,224 8,357 Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024) 5,570 5,570 Rebates payable to partners 6,364 7,289 Other 13,586 19,920 Accrued expenses and other current liabilities $ 84,793 $ 83,997

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Non-Cancelable Purchase Obligations	As of April 30, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2025 $ 66,202 Year ending January 31, 2026 69,593 2027 23,856 2028 8,443 2029 17 Thereafter 1 Total $ 168,112

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Schedule of Changes in Components of Accumulated Other Comprehensive Income	For the three months ended April 30, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income Balance as of January 31, 2024 $ 8,925 $ (100) $ 8,825 Other comprehensive loss, net of tax (3,574) (511) (4,085) Balance as of April 30, 2024 $ 5,351 $ (611) $ 4,740 Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive income, net of tax 2,319 143 2,462 Balance as of April 30, 2023 $ 10,550 $ (476) $ 10,074

Equity Incentive Plans and St_2

Equity Incentive Plans and Stock-Based Compensation (Tables)	3 Months Ended
	Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock option activity during the three months ended April 30, 2024 was as follows: Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value Outstanding as of January 31, 2024 11,080 $ 3.49 7.8 $ 216,010 Granted 1,670 $ 0.10 Exercised (1,428) $ 0.22 Forfeited (40) $ 0.10 Outstanding as of April 30, 2024 11,282 $ 3.41 8.0 $ 175,549 Vested and exercisable as of April 30, 2024 4,779 $ 5.09 6.8 $ 66,332
Schedule of RSU Activity	RSU activity during the three months ended April 30, 2024 was as follows: RSUs Weighted-Average Grant Date Fair Value Per Share Unvested as of January 31, 2024 31,272 $ 19.89 Granted 9,479 $ 21.45 Vested (3,843) $ 21.22 Forfeited (1,497) $ 20.76 Unvested as of April 30, 2024 35,411 $ 20.13
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended April 30, 2024 2023 Cost of subscription services revenue $ 4,276 $ 3,178 Cost of professional services and other revenue 2,470 2,699 Sales and marketing 36,216 33,123 Research and development 29,142 24,773 General and administrative 16,623 21,275 Total $ 88,727 $ 85,048

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts): Three Months Ended April 30, 2024 2023 Class A Class B Class A Class B Numerator: Net loss $ (24,579) $ (4,157) $ (27,186) $ (4,715) Denominator: Weighted-average shares used in computing net loss per share, basic and diluted 487,472 82,453 475,425 82,453 Net loss per share, basic and diluted $ (0.05) $ (0.05) $ (0.06) $ (0.06)
Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share	Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands): Three Months Ended April 30, 2024 2023 Class A Class B Class A Class B Unvested RSUs 32,230 — 37,351 — Outstanding stock options 10,946 — 13,883 — Shares subject to repurchase from RSAs and early exercised stock options 28 — 63 — Shares issuable under ESPP 690 — 897 — Returnable shares issued in connection with business acquisition 274 — 427 — Total 44,168 — 52,621 —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gain (losses)	$ 2.8	$ (0.8)
United States, European Union Countries and Japan | Geographic Concentration Risk | Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	95%		91%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Amount	$ 335,112	$ 289,588
Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Amount	$ 153,111	$ 123,452
Americas | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	46%	43%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Amount	$ 104,627	$ 96,931
Europe, Middle East, and Africa | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	31%	33%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Amount	$ 77,374	$ 69,205
Asia-Pacific | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	23%	24%
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	42%	38%
Japan | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	13%	13%

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 182,300	$ 150,600
Deferred contract acquisition costs	$ 18,467	$ 14,072

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Apr. 30, 2024 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 1,100.6
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	616.2
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 484.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-05-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	62%
Remaining performance obligations, period	12 months

Marketable Securities - Summary

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 790,488	$ 818,246
Gross Unrealized Gains	0	29
Gross Unrealized Losses	(606)	(130)
Estimated Fair Value	789,882	818,145
Cash and cash equivalents, amortized cost	1,146,618	1,061,678
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	978
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	978
Treasury bills and U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	710,071	641,263
Gross Unrealized Gains	0	29
Gross Unrealized Losses	(506)	(100)
Estimated Fair Value	709,565	641,192
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	24,778	1,993
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(60)	(2)
Estimated Fair Value	24,718	1,991
Cash and cash equivalents, amortized cost	6,100
Cash and cash equivalents, fair value	6,100
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	54,661	174,990
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(40)	(28)
Estimated Fair Value	54,621	$ 174,962
Treasury bills
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, amortized cost	19,800
Cash and cash equivalents, fair value	$ 19,800

Marketable Securities - Additio

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 962	$ 0
Interest receivable	$ 3,100	$ 3,300

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Financial assets:
Total marketable securities	$ 789,882	$ 818,145
Treasury bills
Financial assets:
Total cash equivalents	19,800
Corporate bonds
Financial assets:
Total cash equivalents	6,100
Total marketable securities	24,718	1,991
Commercial paper
Financial assets:
Total marketable securities	978
Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	709,565	641,192
Agency bonds
Financial assets:
Total marketable securities	54,621	174,962
Recurring
Financial assets:
Total cash equivalents	525,106	509,053
Total marketable securities	789,882	818,145
Total	1,314,988	1,327,198
Recurring | Money market
Financial assets:
Total cash equivalents	499,276	509,053
Recurring | Treasury bills
Financial assets:
Total cash equivalents	19,765
Recurring | Corporate bonds
Financial assets:
Total cash equivalents	6,065
Total marketable securities	24,718	1,991
Recurring | Commercial paper
Financial assets:
Total marketable securities	978
Recurring | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	709,565	641,192
Recurring | Agency bonds
Financial assets:
Total marketable securities	54,621	174,962
Recurring | Level 1
Financial assets:
Total cash equivalents	519,041	509,053
Total marketable securities	764,186	816,154
Total	1,283,227	1,325,207
Recurring | Level 1 | Money market
Financial assets:
Total cash equivalents	499,276	509,053
Recurring | Level 1 | Treasury bills
Financial assets:
Total cash equivalents	19,765
Recurring | Level 1 | Corporate bonds
Financial assets:
Total cash equivalents	0
Total marketable securities	0	0
Recurring | Level 1 | Commercial paper
Financial assets:
Total marketable securities	0
Recurring | Level 1 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	709,565	641,192
Recurring | Level 1 | Agency bonds
Financial assets:
Total marketable securities	54,621	174,962
Recurring | Level 2
Financial assets:
Total cash equivalents	6,065	0
Total marketable securities	25,696	1,991
Total	31,761	1,991
Recurring | Level 2 | Money market
Financial assets:
Total cash equivalents	0	0
Recurring | Level 2 | Treasury bills
Financial assets:
Total cash equivalents	0
Recurring | Level 2 | Corporate bonds
Financial assets:
Total cash equivalents	6,065
Total marketable securities	24,718	1,991
Recurring | Level 2 | Commercial paper
Financial assets:
Total marketable securities	978
Recurring | Level 2 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	0	0
Recurring | Level 2 | Agency bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 3
Financial assets:
Total	$ 0	$ 0

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 38,302	$ 38,576
Accumulated Amortization	(25,725)	(23,872)
Intangible Assets, Net	12,577	14,704
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,572	28,807
Accumulated Amortization	(18,166)	(16,881)
Intangible Assets, Net	$ 10,406	$ 11,926
Weighted-Average Remaining Useful Life (years)	2 years 7 months 6 days	2 years 9 months 18 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,228	$ 8,266
Accumulated Amortization	(6,829)	(6,306)
Intangible Assets, Net	$ 1,399	$ 1,960
Weighted-Average Remaining Useful Life (years)	1 year 2 months 12 days	1 year 3 months 18 days
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 271	$ 272
Accumulated Amortization	(271)	(266)
Intangible Assets, Net	$ 0	$ 6
Weighted-Average Remaining Useful Life (years)	0 years	2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(459)	(419)
Intangible Assets, Net	$ 772	$ 812
Weighted-Average Remaining Useful Life (years)	6 years 10 months 24 days	7 years

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 2	$ 2.1

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2025	$ 4,615
2026	4,079
2027	2,428
2028	1,153
2029	101
Thereafter	201
Intangible Assets, Net	$ 12,577	$ 14,704

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 89,026
Effect of foreign currency translation	(642)
Ending balance	$ 88,384

Operating Leases - Additional I

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 26,300
Current operating lease liabilities	$ 8,224	$ 8,357
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	14 years

Operating Leases - Summary of L

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Operating lease cost	$ 3,476	$ 3,071
Short-term lease cost	1,123	1,300
Variable lease cost	523	621
Sublease income	0	(532)
Total	$ 5,122	$ 4,460

Operating Leases - Weighted Ave

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Apr. 30, 2024	Jan. 31, 2024
Leases [Abstract]
Weighted-average remaining lease term (years)	10 years 6 months	10 years 8 months 12 days
Weighted-average discount rate	7.20%	7.10%

Operating Leases - Summary of F

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2025	$ 9,097
2026	12,110
2027	11,875
2028	10,444
2029	7,137
Thereafter	49,852
Total operating lease payments	100,515
Less: imputed interest	(29,519)
Total operating lease liabilities	$ 70,996

Operating Leases - Supplemental

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 3,653	$ 2,615
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 7,044	$ 1,993

Condensed Consolidated Balanc_5

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 76,695	$ 87,781
Other current assets	21,451	17,199
Prepaid expenses and other current assets	$ 98,146	$ 104,980

Condensed Consolidated Balanc_6

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 58,072	$ 57,355
Less: accumulated depreciation	(35,331)	(33,373)
Property and equipment, net	22,741	23,982
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	23,706	23,767
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	24,307	21,756
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,708	6,640
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,720	4,560
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 631	$ 632

Condensed Consolidated Balanc_7

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.3	$ 3

Condensed Consolidated Balanc_8

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 22,256	$ 18,458
Withholding tax from employee equity transactions	4,216	3,277
Employee stock purchase plan withholdings	8,483	3,618
Payroll taxes and other benefits payable	5,424	3,888
Income taxes payable	6,833	7,140
Value-added taxes payable	3,837	6,480
Operating lease liabilities, current	8,224	8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024)	5,570	5,570
Rebates payable to partners	6,364	7,289
Other	13,586	19,920
Accrued expenses and other current liabilities	$ 84,793	$ 83,997

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Other Commitments [Line Items]
Letters of credit outstanding	$ 2.8		$ 2.6
Defined contribution plan, contribution cost	6.2	$ 5.6
Litigation Matters
Other Commitments [Line Items]
Loss contingency accrual	0
Product Liability Contingencies
Other Commitments [Line Items]
Loss contingency accrual	0
Other Matters
Other Commitments [Line Items]
Loss contingency accrual	$ 0

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2025	$ 66,202
2026	69,593
2027	23,856
2028	8,443
2029	17
Thereafter	1
Total	$ 168,112

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Sep. 01, 2023
Class of Stock [Line Items]
Charitable contribution recorded as expense	$ 6,564,000	$ 4,215,000
Common Stock | Class A Common Stock
Class of Stock [Line Items]
Repurchase authorized			$ 500,000,000
Repurchased of common shares (in shares)	900
Average price of common shares (in dollar per share)	$ 23.46
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)	2,800
Charitable donation of Class A common stock (in shares)	281	281

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Changes In Components of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 2,016,114	$ 1,920,158
Other comprehensive (loss) income, net of tax	(4,085)	2,462
Ending balance	2,027,004	1,955,537
Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,825	7,612
Other comprehensive (loss) income, net of tax	(4,085)	2,462
Ending balance	4,740	10,074
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,925	8,231
Other comprehensive (loss) income, net of tax	(3,574)	2,319
Ending balance	5,351	10,550
Unrealized Loss on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(100)	(619)
Other comprehensive (loss) income, net of tax	(511)	143
Ending balance	$ (611)	$ (476)

Equity Incentive Plans and St_3

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		1 Months Ended	3 Months Ended
	Jul. 29, 2022	Apr. 22, 2021	Apr. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)			$ 21.26
Intrinsic value of stock options exercised			$ 31.4
Cost not yet recognized for unvested options			$ 122.5
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			1 year 3 months 18 days
Unrecognized compensation expense			$ 3.2
Stock issued at closing subject to clawback provisions (in shares)	0.4
Shares issuable under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)		15.5
Period of shares automatically increase		10 years
Percentage of total number of shares		1%
Number of shares authorized (in shares)			27.2
Weighted-average remaining period			1 month 6 days
Unrecognized compensation expense			$ 0.9
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			2 years 2 months 12 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			2 years 4 months 24 days
Fair value of RSUs vested			$ 87.4
Unrecognized compensation expense			$ 661.6
Class A Common Stock | Shares issuable under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price		85%
Purchase price of common stock, purchase date, percent of market price		85%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase		10 years
Percentage of total number of shares		5%
2021 Stock Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)			202.2

Equity Incentive Plans and St_4

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Stock Options
Outstanding, beginning balance (in shares)	11,080
Granted (in shares)	1,670
Exercised (in shares)	(1,428)
Forfeited (in shares)	(40)
Outstanding, ending balance (in shares)	11,282	11,080
Weighted-Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 3.49
Granted (in dollars per share)	0.10
Exercised (in dollars per share)	0.22
Forfeited (in dollars per share)	0.10
Outstanding, ending balance (in dollars per share)	$ 3.41	$ 3.49
Outstanding, Weighted-Average Remaining Contractual Life (years)	8 years	7 years 9 months 18 days
Outstanding, Aggregate Intrinsic Value	$ 175,549	$ 216,010
Vested and exercisable, Stock Options (in shares)	4,779
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share)	$ 5.09
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 9 months 18 days
Vested and exercisable, Aggregate Intrinsic Value	$ 66,332

Equity Incentive Plans and St_5

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	3 Months Ended
	Apr. 30, 2024 $ / shares shares
RSUs
Unvested, beginning balance (in shares) | shares	31,272
Granted (in shares) | shares	9,479
Vested (in shares) | shares	(3,843)
Forfeited (in shares) | shares	(1,497)
Unvested, ending balance (in shares) | shares	35,411
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 19.89
Granted (in dollars per share) | $ / shares	21.45
Vested (in dollars per share) | $ / shares	21.22
Forfeited (in dollars per share) | $ / shares	20.76
Unvested, ending balance (in dollars per share) | $ / shares	$ 20.13

Equity Incentive Plans and St_6

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 88,727	$ 85,048
Cost of revenue | Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	4,276	3,178
Cost of revenue | Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,470	2,699
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	36,216	33,123
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	29,142	24,773
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 16,623	$ 21,275

Income Taxes (Details)

Income Taxes (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2024 USD ($) negotiation	Apr. 30, 2023 USD ($)
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 3,780	$ 3,632
Effective tax rate	(15.10%)	(12.80%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 2,300
Liability pertaining to uncertain tax positions	$ 500
Number of bilateral transfer pricing negotiations | negotiation	2
Romania | Subsidiaries
Income Tax Examination [Line Items]
Proposed reduction in NOLs	$ 66,700

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (28,736)	$ (31,901)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	569,925	557,878
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	569,925	557,878
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)
Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (24,579)	$ (27,186)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	487,472	475,425
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	487,472	475,425
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)
Class B
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (4,157)	$ (4,715)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	82,453	82,453
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	82,453	82,453
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Class A
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	44,168	52,621
Class A | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	32,230	37,351
Class A | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	10,946	13,883
Class A | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	28	63
Class A | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	690	897
Class A | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	274	427
Class B
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	May 03, 2024 USD ($)
Subsequent Event
Subsequent Event [Line Items]
Investments	$ 35.2